Hepatocellular Carcinoma.

By A. Villanueva. New England Journal of Medicine, 2019

1,607 citations recorded by the source corpus.

Presenting the most up-to-date knowledge of hepatocellular carcinoma, it covers all topics — including those more controversial ones — in this rapidly advancing field, from epidemiology to prevention, from molecular biology to gross pathology, from screening to atypical presentation, from diagnosis to treatment, and from assessment to choice of appropriate treatment. This volume is therefore an important contribution to the field of hepatocellular carcinoma.

Subfields: Epidemiology, Hepatology

View Paper: https://www.semanticscholar.org/paper/788c5e7fe5b68af9b248f1d43cfa6206c9e71d71

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. S. Friedman
2. Gerald I. Shulman
3. R. Loomba
4. Y. Saiman
5. J. Puche
6. J. Bonner
7. D. Clegg
8. B. Palmer

In Hepatology

1. S. Friedman
2. Gerald I. Shulman
3. R. Loomba
4. Y. Saiman
5. J. Puche
6. J. Bonner

Citations in the corpus

• Mechanisms and disease consequences of nonalcoholic fatty liver disease (2021, background): “Efforts to develop more sensitive screening strategies that detect circulating tumor cells or their DNA or specific epigenetic changes using liquid biopsy or other non-invasive technologies are advancing but have not yet been validated sufficiently to be implemented in clinical practice (Chalasani e”